Form 4: Estee Lauder Executive VP Rashida La Lande Reports Stock and Options Grant

Sentiment:

SEC Form 4


Rashida La Lande, Executive VP & General Counsel of Estee Lauder, reports the acquisition of restricted stock units and stock options.

Summary

  • Rashida La Lande, Executive VP & General Counsel of Estee Lauder Companies Inc., filed a Form 4 on August 29, 2024, reporting transactions made on August 27, 2024.
  • The transactions involve the acquisition of restricted stock units (RSUs) and stock options.
  • La Lande acquired 10,768 RSUs that vest in three installments on November 3, 2025, November 2, 2026, and November 1, 2027.
  • She also acquired 43,071 non-annual RSUs that vest in three installments on August 27, 2025, August 27, 2026, and August 27, 2027.
  • Additionally, La Lande acquired stock options for 16,693 shares of Class A Common Stock at an exercise price of $92.87, exercisable in installments from November 3, 2025, November 2, 2026, and November 1, 2027, expiring on August 27, 2034.
  • The reported transactions were made pursuant to the Fiscal 2002 Share Incentive Plan.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. The sentiment is neutral to slightly positive as it suggests continued commitment from a key executive.

Positives

  • The grant of RSUs and stock options aligns La Lande's interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.
  • The vesting schedules encourage continued employment and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedules of the RSUs and the exercisability and expiration of the stock options.

Industry Context

Equity compensation is a common practice in the beauty and personal care industry to attract and retain top talent. Grants of RSUs and stock options are typical components of executive compensation packages.

Comparison to Industry Standards

  • Companies like L'Oreal, Unilever, and Procter & Gamble also utilize equity-based compensation for their executives.
  • The vesting schedules and option terms are generally in line with industry standards for executive compensation packages.
  • The specific amounts of RSUs and stock options granted would be benchmarked against similar roles and company performance within the peer group.

Stakeholder Impact

  • The grant of equity may have a slightly dilutive effect on existing shareholders.
  • The equity grants incentivize the executive to work towards increasing shareholder value.

Key Dates

DateDescription
08/27/2024Date of the reported transactions (grant of RSUs and stock options).
08/29/2024Date the Form 4 was filed.
11/03/2025First vesting date for a portion of the annual RSUs and exercisable date for a portion of the stock options.
08/27/2025First vesting date for a portion of the non-annual RSUs.
11/02/2026Second vesting date for a portion of the annual RSUs and exercisable date for a portion of the stock options.
08/27/2026Second vesting date for a portion of the non-annual RSUs.
11/01/2027Final vesting date for a portion of the annual RSUs and exercisable date for a portion of the stock options.
08/27/2027Final vesting date for a portion of the non-annual RSUs.
08/27/2034Expiration date for the stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.